These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35678047)

  • 1. Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory Perspective.
    Mehrotra S; Bhattaram A; Krudys K; Bewernitz M; Uppoor R; Mehta M; Liu T; Sheridan P; Hershkowitz N; Kozauer N; Bastings E; Dunn B; Men AY
    Clin Pharmacol Ther; 2022 Oct; 112(4):853-863. PubMed ID: 35678047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
    Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
    Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of the New Antiepileptic Drugs for Focal-Onset Seizures in Pediatrics: Role of Extrapolation.
    Arzimanoglou A; D'Cruz O; Nordli D; Shinnar S; Holmes GL;
    Paediatr Drugs; 2018 Jun; 20(3):249-264. PubMed ID: 29616471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizures.
    Villanueva V; Majid O; Nabangchang C; Yang H; Laurenza A; Ferry J; Hussein Z
    Epilepsy Res; 2016 Nov; 127():126-134. PubMed ID: 27595590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic analysis of adjunctive perampanel in subjects with partial-onset seizures.
    Takenaka O; Ferry J; Saeki K; Laurenza A
    Acta Neurol Scand; 2018 Apr; 137(4):400-408. PubMed ID: 29171002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, drug interactions and exposure-response relationship of eslicarbazepine acetate in adult patients with partial-onset seizures: population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses.
    Falcão A; Fuseau E; Nunes T; Almeida L; Soares-da-Silva P
    CNS Drugs; 2012 Jan; 26(1):79-91. PubMed ID: 22171585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures.
    Sunkaraneni S; Ludwig E; Fiedler-Kelly J; Hopkins S; Galluppi G; Blum D
    J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):649-658. PubMed ID: 29948795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.
    Socała K; Wyska E; Szafarz M; Nieoczym D; Wlaź P
    Neuropharmacology; 2019 Nov; 158():107733. PubMed ID: 31377197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.
    Shorvon SD; Bermejo PE; Gibbs AA; Huberfeld G; Kälviäinen R
    Epilepsy Behav; 2018 May; 82():91-103. PubMed ID: 29602083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of second-generation antiepileptic drugs in the pediatric population.
    Chung AM; Eiland LS
    Paediatr Drugs; 2008; 10(4):217-54. PubMed ID: 18590343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures.
    de Biase S; Gigli GL; Nilo A; Romano G; Valente M
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):93-102. PubMed ID: 30577702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric partial and generalized seizures.
    Bebin M
    J Child Neurol; 2002 Jan; 17 Suppl 1():S65-9. PubMed ID: 11918466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.
    Schoemaker R; Wade JR; Stockis A
    Clin Pharmacokinet; 2018 Jul; 57(7):843-854. PubMed ID: 28884437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.